These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35286523)

  • 1. Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study.
    Scott OW; Tin Tin S; Elwood JM; Cavadino A; Habel LA; Kuper-Hommel M; Campbell I; Lawrenson R
    Breast Cancer Res Treat; 2022 May; 193(1):225-235. PubMed ID: 35286523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study.
    Scott OW; TinTin S; Harborg S; Kuper-Hommel MJJ; Lawrenson R; Elwood JM
    Breast Cancer Res Treat; 2023 May; 199(1):195-206. PubMed ID: 36930345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of beta-blockers and risk of contralateral breast cancer.
    Gottschau M; Bens A; Friis S; Cronin-Fenton D; Aalborg GL; Jensen MB; Ejlertsen B; Kroman N; Mellemkjaer L
    Int J Cancer; 2022 May; 150(10):1619-1626. PubMed ID: 34985760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker use and breast cancer outcomes: a meta-analysis.
    Scott OW; TinTin S; Cavadino A; Elwood JM
    Breast Cancer Res Treat; 2024 Aug; 206(3):443-463. PubMed ID: 38837086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.
    Cardwell CR; Pottegård A; Vaes E; Garmo H; Murray LJ; Brown C; Vissers PA; O'Rorke M; Visvanathan K; Cronin-Fenton D; De Schutter H; Lambe M; Powe DG; van Herk-Sukel MP; Gavin A; Friis S; Sharp L; Bennett K
    Breast Cancer Res; 2016 Dec; 18(1):119. PubMed ID: 27906047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
    Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
    J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer.
    Assayag J; Pollak MN; Azoulay L
    Eur J Cancer; 2014 Nov; 50(16):2838-45. PubMed ID: 25204805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.
    Botteri E; Munzone E; Rotmensz N; Cipolla C; De Giorgi V; Santillo B; Zanelotti A; Adamoli L; Colleoni M; Viale G; Goldhirsch A; Gandini S
    Breast Cancer Res Treat; 2013 Aug; 140(3):567-75. PubMed ID: 23912960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.
    Melhem-Bertrandt A; Chavez-Macgregor M; Lei X; Brown EN; Lee RT; Meric-Bernstam F; Sood AK; Conzen SD; Hortobagyi GN; Gonzalez-Angulo AM
    J Clin Oncol; 2011 Jul; 29(19):2645-52. PubMed ID: 21632501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.
    Ganz PA; Habel LA; Weltzien EK; Caan BJ; Cole SW
    Breast Cancer Res Treat; 2011 Sep; 129(2):549-56. PubMed ID: 21479924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
    Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS
    Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
    J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.
    Cardwell CR; Coleman HG; Murray LJ; Entschladen F; Powe DG
    Int J Epidemiol; 2013 Dec; 42(6):1852-61. PubMed ID: 24536096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer.
    Wittayanukorn S; Qian J; Westrick SC; Billor N; Johnson B; Hansen RA
    Am J Clin Oncol; 2018 Sep; 41(9):909-918. PubMed ID: 28537988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
    Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
    Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.
    Raimondi S; Botteri E; Munzone E; Cipolla C; Rotmensz N; DeCensi A; Gandini S
    Int J Cancer; 2016 Jul; 139(1):212-9. PubMed ID: 26916107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.
    Sundbøll J; Schmidt M; Horváth-Puhó E; Christiansen CF; Pedersen L; Bøtker HE; Sørensen HT
    BMC Neurol; 2015 Mar; 15():24. PubMed ID: 25884780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis.
    Løfling LL; Støer NC; Sloan EK; Chang A; Gandini S; Ursin G; Botteri E
    Br J Cancer; 2022 Oct; 127(6):1086-1096. PubMed ID: 35725814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
    Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
    Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of beta blockers in patients with and without a history of myocardial infarction.
    Verma S; Peterson EL; Liu B; Sabbah HN; Williams LK; Lanfear DE
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1161-1168. PubMed ID: 32440720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.